What are the Epidemiological Outcomes of Anti-VEGF Therapy?
Studies have shown that Anti-VEGF therapy significantly reduces the incidence of severe vision loss in patients with AMD and diabetic retinopathy. This has a positive impact on public health, reducing the prevalence of blindness and associated disabilities.
